Emerphed, a subsidiary of Nexus Pharmaceuticals, is a leading provider of innovative and high-quality ephedrine sulfate products for healthcare professionals in the United States. Their expanded EMERPHED ephedrine sulfate family offers ready-to-use options, including the first and only 10 mL syringe, providing simplicity, stability, and safety in the operating room. With a focus on redefining the standards of patient care, Emerphed's ready-to-use ephedrine eliminates the need for dilution, reducing the potential for errors and waste.
By offering a two-year shelf life and a streamlined ordering process, EMERPHED ready-to-use vial simplifies the procurement of ephedrine, while their non-compounded, manufacturer-prepared products align with FDA recommendations for safety. With a range of benefits, including time and resource preservation, reduced preparation errors, and minimized product waste, Emerphed is dedicated to providing healthcare professionals with reliable and efficient solutions for hypotension treatment during anesthesia.
Generated from the website